Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2004 | 1 |
2008 | 1 |
2024 | 0 |
Search Results
2 results
Results by year
Filters applied: . Clear all
Page 1
Development of anaplastic lymphoma kinase (ALK) small-molecule inhibitors for cancer therapy.
Med Res Rev. 2008 May;28(3):372-412. doi: 10.1002/med.20109.
Med Res Rev. 2008.
PMID: 17694547
Review.
In addition, two recent reports have suggested that the ALK fusion, TPM4-ALK, may be involved in the genesis of a subset of esophageal squamous cell carcinomas. ...There are no currently available ALK small-molecule inhibitors approved for clinical cancer therapy; h …
In addition, two recent reports have suggested that the ALK fusion, TPM4-ALK, may be involved in the genesis of a subset of es …
Low-grade sarcomas with CD34-positive fibroblasts and low-grade myofibroblastic sarcomas.
Fisher C.
Fisher C.
Ultrastruct Pathol. 2004 Sep-Dec;28(5-6):291-305. doi: 10.1080/019131290882187.
Ultrastruct Pathol. 2004.
PMID: 15764578
Review.
Many IMT have clonal chromosomal abnormalities involving 2p22-24, and fusion of the ALK gene with tropomyosin 3 (TPM3-ALK) or tropomyosin 4 (TPM4-ALK) is found in a subset....
Many IMT have clonal chromosomal abnormalities involving 2p22-24, and fusion of the ALK gene with tropomyosin 3 (TPM3-ALK) or tropomyosin 4 …
Item in Clipboard
Cite
Cite
ARTICLE TYPE
ARTICLE LANGUAGE
AGE
Filters on the sidebar will be reset to the default list and any currently applied filters will be cleared.